iRepertoire

Enrichment prior to amplification better enables studies of non-coding regions and epigenetic analyses, according to Ubiquity's founder.

Immune sequencing will be done in HudsonAlpha's newly established CLIA laboratory.

Researchers are demonstrating that sequencing the immune repertoire can offer valuable insight into blood cancers, treatment response, and the likelihood of relapse.

NEW YORK (GenomeWeb) – iRepertoire today announced a deal with Wiratech to distribute iRepertoire's reagent kits in parts of Europe.

NEW YORK (GenomeWeb News) – Sequenta has gained the exclusive rights to iRepertoire's IP related to methods of immune cell sequencing for minimal residual disease testing, the two companies said today.

Immune cell profiling company iRepertoire has launched a new line of reagents, amplification, and sequencing services on the Illumina MiSeq system.

The goal is to find personalized biomarkers in the immune system that will lead to better and earlier diagnostics.

T-cell receptor sequencing is "a long way from being used clinically," said Robert Holt, head of sequencing at the BC Cancer Agency's Genome Sciences Center and senior author of a recent paper on the subject.

Sequencing the immune repertoire could provide important insights into the nature of disease and infection, and new companies that offer such sequencing and analysis have recently sprung up.

Pages

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.